Geron reported $38.47M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Amgen AMGN:US $ 14842M 257M
Aurinia Pharmaceuticals Inc AUP:CN 29.32M 8.16M
Bio Techne TECH:US $ 133.99M 18.29M
Cti Biopharma CTIC:US $ 62.34M 46.55M
Cytokinetics CYTK:US $ 80.87M 19.1M
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
Exelixis EXEL:US $ 269.51M 14.18M
Genmab GEN:DC DK 1830M 479M
Geron GERN:US $ 38.47M 1.46M
Gilead Sciences GILD:US $ 10245M 31M
Macrogenics MGNX:US $ 68.86M 1.06M
Novartis NOVN:VX SF 29880M 247M
Novavax NVAX:US $ 1753.42M 101.9M
Pain Therapeutics PTIE:US $ 6.33M 1.69M
Seattle Genetics SGEN:US $ 698.43M 264.6M
YTE INCY:US $ 742.71M 82.39M